Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Motion Tracking and Compensation Feature for the Radixact Treatment Delivery System

K-Number: K182687 · 2018-11-23

ApplicantAccuray Incorporated
Decision Date2018-11-23
Product CodeIYE
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Motion Tracking and Compensation Feature for the Radixact Treatment Delivery System is the device name listed in this FDA 510(k) record. The listed applicant is Accuray Incorporated. It received FDA 510(k) clearance on 2018-11-23 under 510(k) number K182687. The device is classified under product code IYE. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Motion Tracking and Compensation Feature for the Radixact Treatment Delivery System?

Motion Tracking and Compensation Feature for the Radixact Treatment Delivery System is a medical device that received FDA 510(k) clearance on 2018-11-23. The listed applicant is Accuray Incorporated. The 510(k) number is K182687.

When did Motion Tracking and Compensation Feature for the Radixact Treatment Delivery System receive FDA 510(k) clearance?

Motion Tracking and Compensation Feature for the Radixact Treatment Delivery System received FDA 510(k) clearance on 2018-11-23, under 510(k) number K182687.

Who is the listed applicant for Motion Tracking and Compensation Feature for the Radixact Treatment Delivery System?

The FDA 510(k) record lists Accuray Incorporated as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Motion Tracking and Compensation Feature for the Radixact Treatment Delivery System?

The FDA product code for Motion Tracking and Compensation Feature for the Radixact Treatment Delivery System is IYE.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT02761889Hypofractionated Image-Guided Radiotherapy (IGRT) With Organ Motion Mitigation and Urethral Sparing for Prostate CancerCOMPLETED

Other records listing Accuray Incorporated as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K223159Radixact Treatment Delivery SystemK212794Accuray Precision Treatment Planning SystemK202412ClearRT Helical kVCT for the Radixact Treatment Delivery SystemK171837TomoTherapy Treatment Delivery System with iDMSK171086Accuray Precision Treatment Planning SystemK161146Radixact Treatment Delivery System

View all 9 devices →

Related Devices (Code: IYE)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K261856Halcyon, Ethos Radiotherapy System (5.0)Varian Medical Systems, Inc.K252937ThinkQA 3Dosisoft SAK253004LUNA 3DLap GmbH Laser ApplikationenK260792AerFrame Patient Immobilization System (AFPIS)Stabilix, LLCK252258VERIQA RT EPID 3DPtw-Freiburg Physikalisch-Technische-Werkstaetten Dr. PychlaK253962ClearCheck (RADCC V2.7)Radformation, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑